Market Intelligence

Protalix PLX Q1 2026 Earnings Surprise EPS 022 Up Significant Saratoga SAR Q1 2026 Results Miss Estimates EPS 016 vs 056 Infinity INR Q1 2026 Earnings 343 EPS Surges Past 093 Estimates Taoping TAOP Q2 2011 Results Fall Short EPS 39600 Revenue NA Truist TFC Q1 2026 Earnings EPS 109 Beats Estimates Singapore Must Strengthen Position as Trusted AI Financial Hub DPM Gan GSI Technology GSIT Q1 2026 Earnings Preview What to Expect Trilogy Metals TMQ Q1 2026 Underwhelms Revenue Pressure Hits Bottom Line Rites of Passage Updates Colorado Wilderness Vision Quest Program With Extended Solo Fast New York Yankees Face Financial Uncertainty as Concerns Over Aaron Judge Grow Devon Energy Invests 26 Billion to Expand Delaware Basin Presence Gas Prices Near 455 Average Consumer Strategies to Manage Fuel Costs This Travel Weekend Federal Rescheduling Could End Punitive Tax Structure for Cannabis Companies Unlocking Billions Reliance Industries Chairman Mukesh Ambani Outlines Vision for AI Energy and Digital Platforms in Indias Growth Era ABVC BioPharma Inc Q1 2025 Earnings Narrowed Loss Highlights Continued Pipeline Progress Avis Budget Group CAR Q1 2026 Earnings Loss Widens More Than Expected Stock Edges Higher GLW Q1 2026 Earnings Small EPS Beat as Corning Delivers Profitability Focus Bowman Consulting Group Ltd Q1 2026 Earnings Significant EPS Miss Pressures Stock NPWR Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Company Continues Technology Development ZIM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Pagaya Technologies Warrants PGYWW Climb 1255 as LowPriced Warrants Test Key 006 Level Sidus Space SIDU Tumbles 146 as Selling Pressure Intensifies MFS Municipal Income Trust MFM Edges Higher Holding Above Key Support at 506 VALE Holds Steady at 1648 as Iron Ore Markets Stabilize Lyell Immunopharma LYEL Falls Sharply Key Support Levels in Focus After 69 Drop UMB Financial Preferred Stock UMBFO Holds Steady Near Support Amid Consolidation Addex Therapeutics ADXN Holds Gains Amid Biotech Sector Momentum OCCIN Unchanged at 2475 Preferred Stock Consolidates Between Key Levels RXO Inc RXO Consolidates Near 2437 as Support and Resistance Levels Define Trading Range Laureate Education LAUR Gains 127 Approaches Key Resistance Zone EchoStar SATS Slides 33 Testing Key Support Levels Amid Sector Pressure